Literature DB >> 24269570

Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.

Damian M Herz1, Hartwig R Siebner2, Oliver J Hulme2, Esther Florin3, Mark S Christensen4, Lars Timmermann5.   

Abstract

Dopamine deficiency affects functional integration of activity in distributed neural regions. It has been suggested that lack of dopamine induces disruption of neural interactions between prefrontal and premotor areas, which might underlie impairment of motor control observed in patients with Parkinson's disease (PD). In this study we recorded cortical activity with high-density electroencephalography in 11 patients with PD as a pathological model of dopamine deficiency, and 13 healthy control subjects. Participants performed repetitive extension-flexion movements of their right index finger, which were externally paced at a rate of 0.5 Hz. This required participants to align their movement velocity to the slow external pace. Patients were studied after at least 12-hour withdrawal of dopaminergic medication (OFF state) and after intake of the dopamine precursor levodopa (ON state) in order to examine oscillatory coupling between prefrontal and premotor areas during respectively low and high levels of dopamine. In 10 patients and 12 control participants multiple source beamformer analysis yielded task-related activation of a contralateral cortical network comprising prefrontal cortex (PFC), lateral premotor cortex (lPM), supplementary motor area (SMA) and primary motor cortex (M1). Dynamic causal modelling was used to characterize task-related oscillatory coupling between prefrontal and premotor cortical areas. Healthy participants showed task-induced coupling from PFC to SMA, which was modulated within the γ-band. In the OFF state, PD patients did not express any frequency-specific coupling between prefrontal and premotor areas. Application of levodopa reinstated task-related coupling from PFC to SMA, which was expressed as high-β-γ coupling. Additionally, strong within-frequency γ-coupling as well as cross-frequency θ-γ coupling was observed from PFC to lPM. Enhancement of this cross-frequency θ-γ coupling after application of levodopa was positively correlated with individual improvement in motor function. The results demonstrate that dopamine deficiency impairs the ability to establish oscillatory coupling between prefrontal and premotor areas during an externally paced motor task. Application of extrinsic dopamine in PD patients reinstates physiological prefrontal-premotor coupling and additionally induces within- and cross-frequency coupling from prefrontal to premotor areas, which is not expressed in healthy participants.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dynamic causal modelling (DCM); Effective connectivity; Electroencephalography (EEG); Motor system; Oscillatory coupling

Mesh:

Substances:

Year:  2013        PMID: 24269570     DOI: 10.1016/j.neuroimage.2013.11.023

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  22 in total

Review 1.  Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?

Authors:  Paolo Calabresi; Veronica Ghiglieri; Petra Mazzocchetti; Ilenia Corbelli; Barbara Picconi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

2.  Moderate swimming suppressed the growth and metastasis of the transplanted liver cancer in mice model: with reference to nervous system.

Authors:  Q-B Zhang; B-H Zhang; K-Z Zhang; X-T Meng; Q-A Jia; Q-B Zhang; Y Bu; X-D Zhu; D-N Ma; B-G Ye; N Zhang; Z-G Ren; H-C Sun; Z-Y Tang
Journal:  Oncogene       Date:  2015-12-21       Impact factor: 9.867

Review 3.  Effects of levodopa on regional cerebral metabolism and blood flow.

Authors:  Ji Hyun Ko; Renata P Lerner; David Eidelberg
Journal:  Mov Disord       Date:  2014-10-09       Impact factor: 10.338

4.  Subthalamic stimulation modulates cortical motor network activity and synchronization in Parkinson's disease.

Authors:  Daniel Weiss; Rosa Klotz; Rathinaswamy B Govindan; Marlieke Scholten; Georgios Naros; Ander Ramos-Murguialday; Friedemann Bunjes; Christoph Meisner; Christian Plewnia; Rejko Krüger; Alireza Gharabaghi
Journal:  Brain       Date:  2015-01-02       Impact factor: 13.501

Review 5.  Towards understanding neural network signatures of motor skill learning in Parkinson's disease and healthy aging.

Authors:  Evelien Nackaerts; Nicholas D'Cruz; Bauke W Dijkstra; Moran Gilat; Thomas Kramer; Alice Nieuwboer
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

6.  Randomized Controlled Trial of a Home-Based Action Observation Intervention to Improve Walking in Parkinson Disease.

Authors:  Abhishek Jaywant; Terry D Ellis; Serge Roy; Cheng-Chieh Lin; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Arch Phys Med Rehabil       Date:  2016-01-22       Impact factor: 3.966

7.  Psychological Stress Phenocopies Brain Mitochondrial Dysfunction and Motor Deficits as Observed in a Parkinsonian Rat Model.

Authors:  Mariana Grigoruţă; Alejandro Martínez-Martínez; Raul Y Dagda; Ruben K Dagda
Journal:  Mol Neurobiol       Date:  2019-12-14       Impact factor: 5.590

8.  Dynamics of Top-Down Control and Motor Networks in Parkinson's Disease.

Authors:  Li Chen; Patrick Bedard; Mark Hallett; Silvina G Horovitz
Journal:  Mov Disord       Date:  2021-01-06       Impact factor: 9.698

9.  Effects of rhythmic stimulus presentation on oscillatory brain activity: the physiology of cueing in Parkinson's disease.

Authors:  Erik S te Woerd; Robert Oostenveld; Bastiaan R Bloem; Floris P de Lange; Peter Praamstra
Journal:  Neuroimage Clin       Date:  2015-09-02       Impact factor: 4.881

Review 10.  Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.

Authors:  Clare J Finlay; Susan Duty; Anthony C Vernon
Journal:  Front Neurol       Date:  2014-06-12       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.